The arrow plot representing data integration distinguished three groups of subjects: a first stable group composed by ATA+(a) patients with low variability between proteomic and transcriptomic profiles, a second group composed by ATA+(b) and ACA+patients with higher variability and a third group composed by ARA+patients, patients with SLE and HC (figure 1C). The gene discussed is ATM; the disease is systemic lupus erythematosus.